HOFSETH BIOCARE ASA (HBC.OL) Stock Price, Forecast & Analysis
Europe - Euronext Oslo - OSL:HBC - NO0010598683 - Common Stock
HBC.OL Key Statistics, Chart & Performance
The current stock price of HBC.OL is 1.36 NOK. In the past month the price decreased by -17.58%. In the past year, price decreased by -20.93%.
HBC.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ARGX.BR | ARGENX SE | 68.11 | 44.24B | ||
| 1AE.DE | ARGENX SE | 68.21 | 44.30B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 18.82B | ||
| ABVX.PA | ABIVAX SA | N/A | 9.50B | ||
| 2X1.DE | ABIVAX SA | N/A | 9.31B | ||
| GXE.DE | GALAPAGOS NV | N/A | 1.84B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.84B | ||
| NANO.PA | NANOBIOTIX | N/A | 950.81M | ||
| 5CV.DE | CUREVAC NV | 6.1 | 796.20M | ||
| IVA.PA | INVENTIVA SA | N/A | 718.23M | ||
| PHIL.MI | PHILOGEN SPA | 20.53 | 684.22M | ||
| FYB.DE | FORMYCON AG | N/A | 439.10M |
Related stock screener links
About HBC.OL
Company Profile
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Company Info
HOFSETH BIOCARE ASA
Kipervikgata 13
Alesund MORE OG ROMSDAL NO
Employees: 75
Phone: 4773102200
HOFSETH BIOCARE ASA / HBC.OL FAQ
Can you describe the business of HOFSETH BIOCARE ASA?
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
What is the stock price of HOFSETH BIOCARE ASA today?
The current stock price of HBC.OL is 1.36 NOK. The price decreased by -0.73% in the last trading session.
Does HOFSETH BIOCARE ASA pay dividends?
HBC.OL does not pay a dividend.
What is the ChartMill rating of HOFSETH BIOCARE ASA stock?
HBC.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Should I buy HBC stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on HBC.OL.
Can you provide the market cap for HOFSETH BIOCARE ASA?
HOFSETH BIOCARE ASA (HBC.OL) has a market capitalization of 559.98M NOK. This makes HBC.OL a Small Cap stock.
HBC.OL Technical Analysis
HBC.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to HBC.OL. Both the profitability and financial health of HBC.OL have multiple concerns.
HBC.OL Financial Highlights
Over the last trailing twelve months HBC.OL reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS decreased by -9.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.39% | ||
| ROE | -13486.42% | ||
| Debt/Equity | 203.13 |